Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Invesco India Pharma And Healthcare Fund Direct Growth
NAV: 16 Oct '26
₹9.07
Min. for SIP
₹100
Fund size (AUM)
₹435.51 Cr
Expense ratio
3.30%
Rating
--
Holdings (15)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Repo | Unspecified | Repo | 20.56% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 9.58% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.99% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 8.63% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 8.03% |
| Manipal Health Enterprises Ltd | Healthcare | Equity | 7.98% |
| Divi's Laboratories Ltd | Healthcare | Equity | 7.85% |
| Global Health Ltd | Healthcare | Equity | 7.00% |
| Dr. Agarwal’S Health Care Ltd. | Healthcare | Equity | 6.32% |
| CORONA Remedies Ltd. | Healthcare | Equity | 6.13% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 4.93% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 4.86% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 4.72% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 1.99% |
| Net Payables | Unspecified | Net Payables | -7.57% |
See All
Minimum investments
Min. for 1st investment
₹1,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹100
Returns and rankings
Annualised returns
Absolute returns
| Name | 1M | 3M | 6M | All |
|---|---|---|---|---|
| Fund returns | -8.2% | -- | -- | -9.3% |
| Category average (Equity Sectoral) | -- | -3.7% | +12.2% | +173.0% |
| Rank (Equity Sectoral) | -- | -- | -- | -- |
Exit load, stamp duty and tax
Exit load
Exit load of 0.50%, if redeemed within 3 months.
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
AKAditya KhemaniAug 2026 - PresentView details
AK
Aditya Khemani
Aug 2026 - Present
View details
About Invesco India Pharma And Healthcare Fund Direct Growth
Invesco India Pharma And Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Invesco Mutual Fund. This scheme was made available to investors on 24 Jul 2006. Aditya Khemani is the Current Fund Manager of Invesco India Pharma And Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹1,64,284 Cr and the Latest NAV as of 16 Oct 2026 is ₹9.07.
The Invesco India Pharma And Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹1,000. Exit load of 0.50%, if redeemed within 3 months.
;
Investment Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)#16 in India
Total AUM₹1,64,283.60 Cr
Date of Incorporation24 Jul 2006
Launch Date24 Jul 2006
AddressB-1001, B Wing, 10th Floor, Marathon Futurex,N. M. Joshi Marg, Lower Parel,Mumbai, Maharashtra Mumbai 400013
Websitewww.karvymfs.com
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,